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Abstract  
Maternal exposure to tobacco and alcohol is a known cause among others for fetal growth 
restriction (FGR). Clinically, FGR can be subclassified into two forms; intrauterine growth 
restriction (IUGR) and small for gestational age (SGA), based on the severity of the growth 
retardation, and abnormal uterine artery Doppler or cerebro-placental ratio. This study aimed 
at investigating any differential correlation between maternal exposures to these toxins with 
the two clinical forms of FGR. Therefore, a case-contr l study was conducted in Barcelona, 
Spain. 64 FGR, which was further subclassified intoIUGR (n=36) and SGA (n=28), and 89 
matched appropriate for gestational age (AGA) were included. The levels of nicotine (NIC) 
and ethyl glucuronide (EtG), biomarkers of tobacco and alcohol exposure, respectively, were 
assessed in the maternal hair in the third trimester. Our analysis showed 65% of the pregnant 
women consumed alcohol, 25% smoked and 19% did both. The ORs of IUGR was 21 times 
versus 14 times for being SGA with maternal heavy smoking, while with alcohol 
consumption the ORs for IUGR was 22 times versus 37 times for the SGA group. The 
differential correlations between these toxins with the two subtypes of FGR suggest different 
mechanisms influencing fetal weight. Our alarming data of alcohol consumption during 
pregnancy should be considered for further confirmation among Spanish women. 




















Birth weight is a strong predictor of pregnancy outc mes, as well as estimating neonatal 
survival rates, achievement of developmental milestones and health risks   ((Bernstein, 
Horbar, Badger, Ohlsson, & Golan, 2000). The health risks associated with FGR are 
prematurity, sudden infant death syndrome, various metabolic and neurological complications 
and delayed effects into adulthood life (Bamfo & Odibo, 2011; Brodsky & Christou, 2004; 
Cosmi, Fanelli, Visentin, Trevisanuto, & Zanardo, 2011; Hunt, 2007; Ismail & Chang, 2012; 
Longo et al., 2013; Markel, Engelstad, & Poindexter, 2014). Still, the etiology of FGR is 
largely unknown. Therefore, investigating factors causing FGR is crucial due to its impact on 
human health. 
 
Prenatal tobacco and alcohol consumption are considered among the leading causes of FGR 
despite of being also the most modifiable (Almond, Chay, & Lee, 2005; Hammoud et al., 
2005; Ismail & Chang, 2012). In Spain, about 25% of females above the age of 16 smoke 
(How Tobacco Smoke Causes Disease, 2010). The prevalence rate of women consuming 
alcohol during pregnancy is 12% to 15%, with 3% to 4% reporting binge drinking; this data is 
mostly obtained by questionnaires (Bhuvaneswar, Chang, Epstein, & Stern, 2007). However, 
Garcia detected that 45% of his cohort of pregnant women, in Barcelona, consumed alcohol 
using biological matrices (Garcia-Algar et al., 2008). 
 
During gestation, the assessment of maternal smoking and alcohol consumption is either by 
interviewing the mother or by completed questionnaires in the first prenatal visit. Alcohol 
consumption is mostly recorded as the number of drinks consumed however; various 
alcoholic drinks contain different concentrations of alcohol. The same concept can be applied 
for smoking. Furthermore, the majority of pregnant women rarely disclose their smoking and 
drinking habits for the misapprehension that small amounts of alcohol are inconsequential or 
fear of stigma or any legal implications (Stone, 2015)  or living in a society like Spain. In 
Spain, drinking is more mundane and integrated into everyday life with high tolerance of high 
levels of alcohol consumption. Since, there is a high chance of false and/or under reporting, 
then estimating the association between FGR with the exposure to these toxins is challenging.  
 
Yet, various studies established a correlation betwe n FGR with the exposure of these toxins 
(Hellerstedt, Himes, Story, Alton, & Edwards, 1997; Meis et al., 1997). It was shown that 
prenatal smoking increased the rates of FGR and preterm delivery (Hammoud et al., 2005; 
Magee, Hattis, & Kivel, 2004; Windham, Hopkins, Fenster, & Swan, 2000).  For alcohol 
consumption during pregnancy, the risk for FGR was found to be directly proportional with 
the amount of alcohol intake (Mariscal et al., 2006). Also, Lundsberg documented increased 
risk of preterm delivery with maternal alcohol use, which was associated with major 
comorbidities including FGR (Lundsberg, Bracken, & Saftlas, 1997). 
  
Recently, NIC and EtG are used as reliable biomarkers to detect tobacco and alcohol 















Silins & Hogberg, 2011). In the growing hair, these toxins are delivered and retained for long-
term compared to the other biological samples such as blood and urine, which cover only few 
days prior to testing (Jacob, Yu, Shulgin, & Benowitz, 1999; Mistriotis & Andreadis, 2013; 
Pragst & Balikova, 2006; Uematsu, 1993).  
 
Cotinine, which is a major metabolite of nicotine, has been used as a biomarker distributed in 
various body fluids including the blood, saliva and urine (Jung et al., 2012).  However, most 
studies on pregnant women used either blood, saliva or urine samples to detect cotinine levels 
(Bowker, Lewis, Coleman, Vaz, & Cooper, 2014; Polanska, Hanke, Laudanski, & Kalinka, 
2007). Cotinine concentration in body fluids of pregnant women has been shown to differ 
from the normal adult population (Haddow, Knight, Palomaki, & McCarthy, 1988). Dempsey 
documented that during pregnancy, the metabolic clearance of cotinine was significantly 
higher (140%) compared to nicotine (60%), the half-life of cotinine was shorter, the plasma 
levels of cotinine were lower compared to nicotine (D mpsey, Jacob, & Benowitz, 2002).  
 
 
Rebagliato et al found marked differences between anten tal and postnatal cotinine 
concentrations in smokers after controlling for tobacco consumption. The salivary cotinine 
levels during pregnancy was significantly decreased compared with postnatal levels, which 
suggest an altered metabolism and distribution of nicoti e and cotinine during pregnancy, 
with higher clearance rates of cotinine compared with non-pregnant women (Rebagliato et al., 
1998).  
Therefore, we have reason to believe that during pre nancy, cotinine may not be the optimal 
marker used for smoking. 
 
Furthermore, investigations concerning birth weight have led to a new hypothesis, which 
states that FGR, which is defined as estimated fetal weight (EFW) <10th centile, may present 
with two different clinical forms during gestation. The first, with an abnormal uterine artery 
Doppler or cerebro-placental ratio, and/or growth centile below the 3rd centile, with poorer 
perinatal outcome is called “intrauterine growth rest iction” (IUGR). The second, with normal 
Doppler studies, with near-normal perinatal outcome, is termed “small for gestational age” 
(SGA) (Figueras & Gratacos, 2014). 
 
Therefore, a prospective case-control study was carried out to evaluate maternal exposure to 
smoking and alcohol, determined by the levels of NIC and EtG, in the maternal hair, in a 
Southern European population. Also, to explore any differential correlations between the 
detected levels of these compounds with the two different clinical subtypes of FGR. 
Materials and methods  
Study population 
Pregnant women were recruited from Barcelona Center of Maternal-Fetal and Neonatal 
Medicine, Hospital Sant Joan de Déu and Hospital Clínic, University of Barcelona, Spain. 















gestational age (LGA), defined by birth weight >95th centile, maternal diagnosis with any 
morbidity related or unrelated to pregnancy including chronic hypertension, diabetes, 
autoimmune disorders, cardiac and renal health problems. The institutional Hospital Ethical 
Committee (PIC-86-14) approved the research protocol for this study. 153 patients were 
enrolled in the study. Each patient signed an informed consent after receiving a thorough 
explanation of the study, prior to sample collection.  
 
After delivery for cases ascertainment, birth weights were recalculated in centiles, adjusted 
for the gestational age at delivery and neonatal sex using reference curves (Figueras et al., 
2008). The patients were divided into three groups: AGA, IUGR and SGA based on centiles, 
the cerebro-placental ratio and uterine artery pulsatility index values in the last ultrasound in 
the third trimester.. The AGA group is defined as the EFW >10th centile, while IUGR is 
determined as the EFW is <3rd or <10th centile with cerebro-placental ratio <5th and/or mean 
uterine artery pulsatility index >95th centile pathological Doppler, while SGA group is the 
EFW between 3rd and 10th centile with normal feto-placental Doppler. The total number of 




Hair samples were collected from the recruited patients in their late third trimester of 
pregnancy. Approximately 100-200 mg of hair was collected by cutting as close to the scalp 
as possible from the vertex on the back of the head. Each cm of the scalp hair reflects 
approximately one month of past exposure (Uematsu, Mizuno, Nagashima, Oshima, & 
Nakamura, 1995). The proximal 1 cm of the hair represents last month’s exposure, therefore 
the whole length of the hair may replicate the averg  dose of exposure during pregnancy. 
The minimum hair length collected was 9 cm. The end closest to the scalp was clearly marked 
and stored at room temperature until analysis. Hairs mples were gathered independently of 





Analytes under investigation were measured by ultra-high performance liquid 
chromatography tandem mass spectrometry (UHPLC-MS/MS). Briefly, total segments were 
washed with 2.5 mL dichloromethane and 2.5 mL methyl alcohol and after dried, reduced in 
short cuts and processed using a ball mill (mixer mill MM 200; Retsch, GmbH & Co., Haan, 
Germany) for 30 min at 30 amplitude units until obtaining a fine grey powder. 25 milligrams 
of this powder were weighed in a glass tube and were added to 10 ng of N-ethylnorcotine (25 
µg/mL) and 10 pg of EtG-d5 (0.05 µg/mL). Internal standards used for NIC and EtG 
determination, respectively, and treated with 500 µL M3 buffer reagent (Comedical, Trento, 
Italy) for 1 h at 100 °C. Then, the treated samples w re cooled at room temperature and a 
sample volume of 10 µL was injected in UHPLC-MS/MS. For EtG analysis, M3 buffer 
reagent extract was directly injected while for NIC, 100 µL of the M3 buffer reagent extract 















a triple quadrupole mass spectrometer operated in multiple reaction monitoring (MRM) mode 
via positive electrospray ionization. MRM transitions were m/z 163.1 > 117.0, 163.1 > 132.6 
for NIC, and m/z 221.1→75.0, 221.1→85.0, for EtG and m/z 226.0→75.0, 226.0→85.0 for 
EtG-d5. The validated method showed a limit of quantification at 0.1 ng/mg and a limit of 
detection at 0.03 ng/mg for NIC and a limit of quantification at 7 pg/mg, and limit of 
detection at 3 pg/mg for EtG.  
 
NIC levels were divided into three categories: Category 1; low exposure (<0.9 ng/mg), 
Category 2; active smokers (1 – 3 ng/mg) and Category 3; heavy smokers (>3 ng/mg) (Pascal 
Kintz, Russell, Baber, & Pichini, 2015). Likewise, EtG levels were distributed into three 
categories; abstinence (< 7pg/mg), social or excessiv  consumption (>7 and <30 pg/mg), and 
the chronic excessive consumption group (>30 pg/mg) (P. Kintz, 2015). 
 
Statistical analysis 
IBM SPSS 24.0 for windows was used for the statistical analysis. Descriptive data were 
calculated prior to any correlation analysis. Results presented as mean and ± standard 
deviation (SD) or median and interquartile range (IQR), after investigating normality 
distribution by Shapiro-Wilk test. Comparisons among the groups were performed using 
parametric [Analysis of variance (ANOVA) and posthoc test] and non-parametric [Kruskal-
Wallis and Mann Whitney] tests depending on data normality. Correlation analyses between 
maternal NIC and EtG detected levels with the two clinical subgroups of FGR were evaluated 
using regression models by adjusting for covariates including maternal age, gestational age, 





Background characteristics are presented in Table 1. In general, we did not detect major 
differences between the three groups AGA, IUGR and SGA regarding the maternal age, 
gestational age and BMI. We noted that the number of nulliparous and multiparous women in 
the FGR group were 34 (22%) and 30 (20%), respectively. Among the 153 patients, FGR 
were 64 (42%). In the FGR group, 42 (66%) of the neonates were males and 22 (34%) were 
females. While in the AGA group, 41(46%) of the neoates were males and 48 (54%) were 
females. We detected a significant differences betwe n mean values of the birth weight 
among the three groups, at the p<.05 level [F (2, 150) = 187.7, p = 0.000].  Post hoc 
comparisons using the Tukey test indicated that the mean of AGA (M = 3296, SD = 299) was 
significantly higher than the IUGR (M = 2069, SD = 421) and SGA (M = 2741, SD = 245). 
Also, IUGR mean values was significantly higher (M = 2069, SD = 421) than SGA group.” 
 
 

















Table 1.  Demographic data of the recruited pregnant women. n: number of patients; (%): 
percentage of the total; SD: standard deviation; AGA: appropriate for gestational age; IUGR: 
intrauterine growth restriction; SGA: small for gestational age; Analysis of variance 


















Fig 1. Neonatal birth weights of the three groups. Mean birth weights of the AGA (white), 
IUGR (grey) and SGA (dashed) groups are presented, significant differences in the birth 
weight of the AGA compared to the IUGR and SGA (p<0.001). Error bars represent standard 
deviations (SD). Increased mean birth weight of the SGA compared to the IUGR group 
(p<0.001). AGA: appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: 
small for gestational age; Analysis of variance (ANOVA) and post hoc comparisons using the 


















The maternal hair detected levels of NIC in the thre groups are illustrated in Table 2.  
 
Table 2. Maternal hair levels of NIC detected in the ree groups. N: number of samples; NIC: 
nicotine; AGA: appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: 
small for gestational age; SD: standard deviation; IQR: interquartile range. Kruskal-Wallis 
and Mann Whitney test were used to compare the levels of NIC; ***p<0.001. 
 
A Kruskal-Wallis H test showed that there was a statistically significant difference in the 
maternal hair levels of NIC between the different groups, χ2 (2) = 19.59, p<0.001, with a mean 
rank of 63 for AGA, 85 IUGR and 109 for SGA. Using a Mann-Whitney U test, we detected a 
significant increase in the maternal hair levels of NIC in all FGR compared to the AGA group 
(U = 1656, p<0.001). Also, NIC levels in each of FGR subgroups; IUGR (U= 1174, p <0.01) 
and SGA (U = 482, p<0.001) showed a significant increase compared to AGA (Figure 2). 





Figure 2. Box and whisker plot of maternal hair levels of NIC (ng/mg) in the AGA (white 
box), IUGR (grey box) and SGA (dashed box). Boxes represent the 25th and 75th percentiles. 
The median is the bold central line, whiskers denot the minimum and maximum values and 
circles indicate outliers. Error bars represent standard deviations (SD). Significant increases in 
the levels of NIC in IUGR, and SGA compared to the AGA group were noted. NIC: nicotine; 
AGA, appropriate for gestational age; IUGR, intrauterine growth restriction; SGA, small for 
gestational age.  Kruskal-Wallis and Mann Whitney tst were used to compare the levels of 
NIC; ***p<0.001.    
 
We, also, calculated the distribution of the mothers and their neonates among the three 
categories of NIC exposure. Our analysis showed that 24% (37/153) of mothers were 
smokers, 16 % (25/153) of the smoking mothers were active smokers and 8 % (12/153) were 
heavy smokers.  The percentages of FGR born in the category 1(low exposure), category 2 
(active smokers) and category 3 (heavy smokers) were 39, 60 and 91 %, respectively (Figure 
3).  
    
 
Figure 3. Percentages of the neonates in each of the three groups AGA (white), IUGR (grey) 
and SGA (dashed), distributed among the three categories of NIC levels. AGA: appropriate 
for gestational age; IUGR: intrauterine growth restriction; SGA: small for gestational age.  
 
Our linear regression analysis showed a significant negative correlation between the maternal 
hair levels of NIC with birth weight (F (1, 151) =11.02, p≤ 0.001), with an R2 of 0.68. Our 
results did not change with adjusting for other covariates, however the gestational age (ß=0.5, 
















In the binary regression analysis of birth weight as outcome (AGA and FGR), and the NIC 
levels (continuous variable) as exposure, the odds ratio (ORs) of being FGR was 1.4 
compared to the AGA group {p<0.05, 95% CI (1.0 -1.9)}. Our multinomial regression 
analysis showed that the ORs for either being IUGR {p<0.05, 95% CI (1.0 -2.0)} or SGA 
{p<0.05, 95% CI (1.0 -1.9)} was 1.4 compared to theAGA group among smoking mothers.  
Upon adjusting for the covariates, the results did not differ however; the male sex was 
significantly {p<0.05, 95% CI (0.2 -1.0)} influencing the IUGR group.  
 
Binary Regression analysis of birth outcome (AGA and FGR), using the NIC categories as 
exposure, we noted that ORs of being born with FGR was 2 times {p<0.001, 95% CI (1.0- 
6.7)} if mothers were active smokers compared to the low exposure group. Also, the ORs of 
being born with FGR was 20 times {p<0.001, 95% CI (2.60- 167.73)} if mothers were heavy 
smokers compared to the low exposure group. No changes were detected with adjusting for 
the covariates. 
 
Using the exposure categories of NIC, in the multinomial regression model we noted that ORs 
of being IUGR {p<0.01, 95% CI (2.5 - 81.4)} was 21 times while the ORs was 14 times for 
being SGA {p<0.05, 95% CI (1.4 -45.9)} when mothers were heavy smokers. When mothers 
were active smokers, the ORs for being born SGA was 3.5 times {p<0.05, 95% CI (1.2 -9.8)}   
however the results for IUGR did not reach significan e [ORs=1.01 {p= 0.09, 95% CI (0.3 -




The maternal hair detected levels of EtG in the thre groups are illustrated in Table 3.  
Table 3. Maternal hair levels of EtG detected in the ree groups. EtG: ethyl glucuronide; 
AGA: appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: small for 
gestational age; SD: standard deviation; IQR: interqua tile range. Kruskal-Wallis and Mann 
Whitney test were used to compare the levels of EtG; ***p<0.001. 
A Kruskal-Wallis H test showed that there was a statistically significant difference in the 
maternal hair levels of EtG between the different groups, χ2 (2) = 68.57, p<0.001, with a 
mean rank of 52 for AGA, 109 IUGR and 115 for SGA. Using a Mann-Whitney U test, we 
detected a significant increase in the maternal hair levels of EtG in all FGR compared to the 
AGA group (U = 595, p<0.001). Also, the EtG levels were significantly increased in each of 
IUGR (U= 411, p<0.001) and SGA (U= 184, p<0.001) compared to the AGA group (Figure 
4).  However, the maternal hair EtG levels were not different when the IUGR and the SGA 
groups were compared. 
 
Figure 4. Box and whisker plot of maternal hair levels of EtG (pg/mg) in the AGA (white 
box), IUGR (grey box) and SGA (dashed box). Boxes represent the 25th and 75th percentiles. 















circles indicate outliers. Error bars represent standard deviations (SD). Significant increases in 
the levels of EtG in IUGR, and SGA compared to the AGA group were noted. EtG: ethyl 
glucuronide; AGA, appropriate for gestational age; IUGR, intrauterine growth restriction; 
SGA, small for gestational age.  Kruskal-Wallis and Mann Whitney test were used to compare 
the levels of EtG; ***p<0.001.    
 
We used the three categories of EtG exposure to stratify the distribution of the participants 
and their neonates in our cohort. Our analysis showed that 65% (99/153) of the pregnant 
women belonged to the social and chronic excessive dr nking categories, and 35% (54/153) of 
the pregnant patients were in the abstinent category. The percentages of the neonates in each 
of the three groups, detected in each category of the E G levels are shown in Figure 5. 
Figure 5. Percentages of the neonates in each of the three groups AGA (white), IUGR (grey) 
and SGA (dashed), distributed among the three categories of the EtG levels. AGA: 
appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: small for 
gestational age. 
 
Our linear regression model analysis using birth weight as a numerical outcome and the 
maternal hair levels of EtG as a predictor, we detect d a negative correlation between 
maternal hair levels of EtG and birth weight (F(1 , 51 )=37.2, p≤0.001), with an R2 of 0.2. 
These results did not change with adjusting with the other covariates; however, the gestational 
age showed significant influence on birth weight (ß=0.5, p<0.001).  
 
Binary regression analysis of birth weight outcome (AGA and FGR) and EtG levels 
(continuous variable) as exposure showed that the ORs of being born with FGR was 1.3 if 
mothers consumed alcohol during pregnancy {p<0.001, 95% CI (1.2- 1.4)} compared to the 
AGA group. Multinomial regression analysis showed the same ORs of 1.3 {p<0.001, 95% CI 
(1.2- 1.5)} for either being IUGR or SGA when mothers consumed alcohol during pregnancy. 
Upon adjusting for the covariates, our results showed that the maternal age (p<0.05) and the 
gestational age (p<0.001) were the only covariates, which showed significance only in the 
IUGR group. 
 
Binary Regression analysis of birth outcome (AGA and FGR), using the EtG categories as 
exposure, we noted that ORs of being born with FGR was 28 {p<0.001, 95% CI (8.2- 97.4)} 
if mothers consumed alcohol socially compared to the abstinent group. In the multinomial 
regression model, using the EtG categories as exposure, the ORs of being born IUGR was 23 
times {p<0.001, 95% CI (5.2- 101.4)} and was 38 times {p<0.001, 95% CI (4.9- 288.4)} for 
being born SGA when mothers consumed alcohol socially compared to the abstinent category. 
No changes were detected with adjusting for the covariates.  
 
Cross tabulation showing the distribution of maternal exposure to smoking and alcohol during 
















Table 4. Cross tabulation of the maternal exposure to smoking and alcohol during pregnancy. 
EtG: ethyl glucuronide; NIC: nicotine; Cat: category. 
 
 
Our analysis showed that 46 % (70/153) pregnant women consumed alcohol but they did not 
smoke. About 19 % (29/153) smoked and consumed alcohol during pregnancy. Only 30% are 
exposed to low levels of alcohol and smoking. The percentage of FGR born to mothers who 
smoked was 37.5 % (24/64) and to those who consumed alcohol was 95% (61/64).  Also, we 
detected a significant correlation between maternal hair levels of NIC and EtG (r = 0.3, 
p<0.001). Our regression model to predict the impact of exposure to both toxins, the OR of 
being born with FGR was 3.6 (p<0.05) when mothers smoked and consumed alcohol during 
pregnancy compared to the AGA group. 
 
In our linear model to investigate the direct influence of maternal alcohol consumption by 
adjusting for smoking, we detected that the alcohol consumption was the main predictor 
influencing birth weight {p<0.001, 95% CI (1.2-1.5)}. Likewise, in binary regression model, 
the maternal EtG exposure was significantly correlated to FGR {p<0.001, 95% CI (1.2-1.4)} 
while adjusting for maternal smoking. In the multinomial regression model, maternal alcohol 





Our analysis showed that the percentage of women, who smoked were 24 % and consumed 
alcohol were 65 % during pregnancy. The percentage of patients who actively smoked and 
consumed alcohol simultaneously were 19 %. Our datashowed higher percentage of alcohol 
consumption among pregnant women compared to the previously published data.  
 
The percentage of FGR born to mothers who smoked was 37.5 % and those who were born to 
alcohol consuming was 95%.  Also, we detected increased levels of both NIC and EtG in the 
maternal hair of FGR compared to the AGA group.  Alongside, there was an increased risk 
for being an IUGR when mothers were active smokers. In contrast, there was an increased 




In general, our study was able to replicate previous findings regarding the negative influence 
of maternal exposure to these toxins and FGR (Aliyu et al., 2009; O'Leary, Nassar, 
Kurinczuk, & Bower, 2009; Yang et al., 2001). However, we detected risk differences 
between the FGR two clinical subtypes with maternal tobacco and alcohol exposure. This 
finding may reflect different mechanisms affecting birth weight. Yet, the biological 
mechanism through which maternal smoking and alcohol consumption affect fetal birth 
weight is to be determined. The most accepted theory is that cigarette smoke contains carbon 















reduction (Wickstrom, 2007). While alcohol crosses freely both the placenta and the fetus’ 
blood–brain barrier (Ross, Graham, Money, & Stanwood, 2015), which may also affect fetal 
growth. It has been shown that the fetus is exposed longer to the same amount of alcohol than 
the mother, as the fetus has less alcohol dehydrogenase to metabolize the alcohol than does 
the mother  (Flynn, Marcus, Barry, & Blow, 2003), causing hypoxia, impaired cell 
proliferation and affect placental development (Abel, 1982) and Fetal Alcohol Spectrum 
Disorders (FASD). FASD has a major negative impact on fetal neurodevelopment and 
cognitive functions and fetuses may present with reduc d weight (Squeglia, Jacobus, & 
Tapert, 2009). We reasoned that the dissimilarities in the risk we noted between the FGR 
clinical subtypes as a result of maternal exposure to smoking and alcohol due to the different 
toxic components in each of these toxins and their various metabolite pathways in the mother 
and fetus. 
 
Smoking and alcohol consumption tend to be highly related, and several studies found it 
challenging to distinguish between the effects of the two toxins on fetal weight. However, it 
has been suggested that maternal smoking and alcohol intake during pregnancy may have a 
synergistic effect that may lead to an increased likelihood of FGR (Odendaal, Steyn, Elliott, & 
Burd, 2009). Our results showed that the reduced birth weight was m inly driven by maternal 
alcohol consumption and maternal smoking may aggravate the negative influence of maternal 
alcohol consumption on birth weight.  
 
Despite of the consistent published association between maternal alcohol consumption and 
FGR, the negative correlation between maternal consumption of moderate amounts of alcohol 
and FGR has been controversial (Chiaffarino et al., 2006; Day et al., 1989; Passaro, Little, 
Savitz, & Noss, 1996; Shu, Hatch, Mills, Clemens, & Susser, 1995; Windham, Fenster, 
Hopkins, & Swan, 1995). From a clinical prospective, women are advised to wi hhold tobacco 
and alcohol consumption during pregnancy. They are ev n encouraged to abstain alcohol 
intake prior to getting pregnant, as there is no safe drinking level during pregnancy. However, 
our results confirmed that women residing in Barcelona continued to smoke and consume 
alcohol during gestation. Even more, the high percentage of women consuming alcohol 
during pregnancy is an alarming result as it reflects women’s behavior during their pregnancy. 
Spanish society is well known with a long-lasting tradition of alcohol consumption and is 
labelled as ‘wet drinking cultures’ which has high tolerance to high levels of alcohol 
consumption and the consequences of such behavior (Gordon, Heim, & MacAskill, 2012). 
Public awareness campagnas should be implemented targeting maternal behavior and habits 
during gestation in such high-risk society and their implication on fetal wellbeing and 
pregnancy outcomes, in parallel to defining screening tests to detect the high-risk group. 
Hence, the consistent use of a validated screening test should improve the identification of 
prenatal alcohol use. 
 
Of note, our study has several limitations. We are aware of the relatively small sample size in 
in each of the groups, and thus the results warrants fur her confirmation in larger-scale, well-
designed studies  and to clearly examine the unique contribution of varying maternal 















point worth considering is the EtG levels in the maternal hair samples differentiate between 
moderate social drinking and chronic alcohol abuse. This enables us to correlate the adverse 
outcomes with the estimated amounts of consumed alcohol. However, this marker lacks the 
ability to neither confirm absolute abstinence nor estimate previous alcohol consumption 
(Pascal Kintz et al., 2015), which creates uncertainty about the effects of low levels of alcohol 
consumption during pregnancy. 
To our knowledge, this is the first report investiga ng the correlation between the levels of 
NIC and EtG detected in the maternal hair with different clinical small fetuses' subgroups. 
Our results showed differential correlations between maternal alcohol consumption with the 
SGA, and selective association between maternal smoking and the IUGR group, which is 
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Table 1.  Demographic data of the recruited pregnant women. n: number of patients; (%): 
percentage of the total; SD: standard deviation; AGA: appropriate for gestational age; IUGR: 
intrauterine growth restriction; SGA: small for gestational age; Analysis of variance 
(ANOVA) and posthoc test: *** p <0.001. 
 
 
 AGA Group IUGR Group SGA Group 
n (%) 89 (58%) 36 (24%) 28 (18%) 
Maternal Age, Mean (SD) 32 (5) 34 (4) 30 (5) 
Gestational Age, Mean (SD) 39 (1.4) 37 (2.1) 39 (1.7) 
BMI (kg/m2) 23.2 23.6 (4.8) 23 
Parity 
Nullipara, n (%) 45 (29%) 18 (12%) 16 (11%) 
Multipara, n (%) 44 (29%) 18 (12%) 12 (8%) 
Neonate sex 
Female, n (%) 48 (31%) 11 (7%) 11 (7%) 
Male, n (%) 41 (27%) 25 (16%) 17 (11%) 














Table 2. Maternal hair levels of NIC detected in the three groups. N: number of samples; NIC: 
nicotine; AGA: appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: 
small for gestational age; SD: standard deviation; IQR: interquartile range. Kruskal-Wallis 









AGA 89 0.51 (1.1) 0.19 (0.4) 0.2 
IUGR 36 4.4 (12) 0.4 (1.7)*** 0.5 





















AGA 89 7.6 (5.1) 6.7 (3.5) 6.8 
IUGR 36 15.3 (8.4) 14 (11)*** 14 
SGA 28 14.5 (4.5) 14 (6)*** 14 
Table 3. Maternal hair levels of EtG detected in the three groups. EtG: ethyl glucuronide; 
AGA: appropriate for gestational age; IUGR: intrauterine growth restriction; SGA: small for 
gestational age; SD: standard deviation; IQR: interquartile range. Kruskal-Wallis and Mann 

























46 8 0 
Cat 2 
Social or Excessive 
Consumption 




2 0 1 
 
Table 4. Cross tabulation of the maternal exposure to smoking and alcohol during pregnancy. 
















































































• Our results showed selective correlations between maternal hair levels of NIC and EtG 
with the clinical subtypes of FGR. 
• These results suggest different mechanisms affecting fetal weight.  
• Alcohol consumption was the main factor affecting fetal birth weight compared to 
tobacco.  
• The increased detected levels of EtG in the maternal hair of pregnant women in 
Barcelona is alarming as it reflects maternal unawareness of the negative influences of 
alcohol of fetal wellbeing.  
